EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY-NC 4.0

A Proposed Research Agenda for Ethical, Legal, Social, and Historical Studies at the Intersection of Infectious and Genetic Disease

François Cholette, Paul J McLaren iD

Journal of Law, Medicine & Ethics · 2024

DOI: 10.1017/jme.2024.114 ↗

Kurz gefasst

Kommentar in der Zeitschrift Journal of Law, Medicine & Ethics, 2024. Verfasst von François Cholette und 1 weiteren Autor:innen. Beteiligte Einrichtung: NATIONAL HIV AND RETROVIROLOGY LABORATORIES, NATIONAL MICROBIOLOGY LABORATORY AT THE J.C. WILT INFECTIOUS DISEASES RESEARCH CENTRE, PUBLIC HEALTH AGE…. Hauptthemen laut MEDLINE: COVID-19. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the past two decades there has been a rapid expansion in our understanding of how human genetic variability impacts susceptibility and severity of disease. Through applications of genome-wide association studies, genome and exome sequencing, researchers have made thousands of discoveries of genetic variants that impact risk of common and rare disorders affecting millions of people. Although these techniques have been primarily applied to highly prevalent chronic disorders such as diabetes 1 and cardiovascular disease 2 , infectious diseases have proven to not be immune to genome-wide association, with studies of Tuberculosis 3 , HIV 4 and SARS-CoV2 5 , to name but a few, identifying host susceptibility loci across the genome. Unlike non-communicable diseases, infectious diseases have the unique element of impacting not only the affected the host, but those who may be most vulnerable to acquiring the infection. Thus, genetic variants that impact one individual’s susceptibility to and severity of an infection may also have broader implications to public health, as was brought into keen focus during the COVID-19 pandemic. Therefore, as we begin to apply the knowledge gained from genomic studies in the clinic or into policy, there are unique ethical, legal, and social implications (ELSI) at the intersection of infectious diseases and human genomics. In this issue of the Journal of Law, Medicine and Ethics , Jose et al attempt to address this need by proposing a research agenda for ELSI studies at what they term the “blurred boundaries” of infectious and genetic diseases. 6

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansCommunicable DiseasesGenetic Diseases, InbornGenetic Predisposition to DiseaseGenome-Wide Association StudySARS-CoV-2

Stichwörter der Autor:innen

EthicsGeneticsGenomicsInfectious DiseasesResearch Agenda

Autor:innen und Institutionen

  • NATIONAL HIV AND RETROVIROLOGY LABORATORIES, NATIONAL MICROBIOLOGY LABORATORY AT THE J.C. WILT INFECTIOUS DISEASES RESEARCH CENTRE, PUBLIC HEALTH AGENCY OF CANADA, WINNIPEG, CANADA.
  • DEPARTMENT OF MEDICAL MICROBIOLOGY AND INFECTIOUS DISEASES, UNIVERSITY OF MANITOBA, WINNIPEG, CANADA.

ORCID-Profile: Paul J McLaren

Zitieren

APA

Cholette, F., & McLaren, P. J. (2024). A Proposed Research Agenda for Ethical, Legal, Social, and Historical Studies at the Intersection of Infectious and Genetic Disease. Journal of Law, Medicine & Ethics. https://doi.org/10.1017/jme.2024.114

Vancouver

Cholette F, McLaren PJ. A Proposed Research Agenda for Ethical, Legal, Social, and Historical Studies at the Intersection of Infectious and Genetic Disease. Journal of Law, Medicine & Ethics. 2024. doi:10.1017/jme.2024.114

BibTeX
@article{Cholette2024,
  author = {Cholette, François and McLaren, Paul J},
  title = {A Proposed Research Agenda for Ethical, Legal, Social, and Historical Studies at the Intersection of Infectious and Genetic Disease},
  journal = {Journal of Law, Medicine & Ethics},
  year = {2024},
  doi = {10.1017/jme.2024.114}
}
Kostenlos starten →